Upstream Bio (UPB) Total Liabilities (2023 - 2026)

Upstream Bio's Total Liabilities history runs 4 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 33.15% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $14.1 million (up 33.15% YoY), while the FY2025 annual figure was $14.0 million, up 17.98% from the prior year.
• Total Liabilities for Q1 2026 stood at $14.1 million, roughly flat from $14.0 million in the prior quarter.
• The five-year high for Total Liabilities was $14.1 million in Q1 2026, with the low at $9.4 million in Q4 2023.
• The 4-year median for Total Liabilities is $12.0 million (2024), against an average of $12.1 million.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities grew 3.91% in 2025, then soared 33.15% in 2026.
• Upstream Bio's Total Liabilities stood at $9.4 million in 2023, then increased by 26.39% to $11.9 million in 2024, then increased by 17.98% to $14.0 million in 2025, then advanced by 0.41% to $14.1 million in 2026.
• Business Quant data shows UPB's Total Liabilities at $14.1 million in Q1 2026, $14.0 million in Q4 2025, and $12.6 million in Q3 2025.